| Year |
Citation |
Score |
| 2023 |
Davis SE, Cirincione AB, Jimenez-Torres AC, Zhu J. The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. International Journal of Molecular Sciences. 24. PMID 37895020 DOI: 10.3390/ijms242015340 |
0.514 |
|
| 2022 |
Davis SE, Ferris MJ, Ananthan S, Augelli-Szafran CE, Zhu J. . The Journal of Pharmacology and Experimental Therapeutics. PMID 36456195 DOI: 10.1124/jpet.122.001291 |
0.675 |
|
| 2022 |
Strauss MJ, Porter KD, Quizon PM, Davis SE, Lin S, Yuan Y, Martinez-Muniz GA, Sun WL, Zhan CG, Zhu J. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. Plos One. 17: e0275182. PMID 36170295 DOI: 10.1371/journal.pone.0275182 |
0.827 |
|
| 2022 |
Zhu J, Quizon PM, Wang Y, Adeniran CA, Strauss MJ, Torres AJ, Patel P, Cirino TJ, Eans SO, Hammond HR, Deliscar LS, O'Hara P, Saini SK, Ofori E, Vekariya RH, et al. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice. Neuropharmacology. 109239. PMID 36126727 DOI: 10.1016/j.neuropharm.2022.109239 |
0.814 |
|
| 2022 |
Davis S, Zhu J. Substance abuse and neurotransmission. Advances in Pharmacology (San Diego, Calif.). 93: 403-441. PMID 35341573 DOI: 10.1016/bs.apha.2021.10.007 |
0.534 |
|
| 2021 |
Adeniran C, Yuan Y, Davis SE, Lin C, Xu J, Zhu J, Zhan CG. Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat. Acs Chemical Neuroscience. PMID 33886267 DOI: 10.1021/acschemneuro.0c00792 |
0.641 |
|
| 2021 |
Quizon PM, Yuan Y, Zhu Y, Zhou Y, Strauss MJ, Sun WL, Zhan CG, Zhu J. Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 33537927 DOI: 10.1007/s11481-021-09984-5 |
0.837 |
|
| 2020 |
Strauss M, O'Donovan B, Ma Y, Xiao Z, Lin S, Bardo MT, Ortinski PI, McLaughlin JP, Zhu J. [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Tat Protein. The Journal of Pharmacology and Experimental Therapeutics. PMID 32461322 DOI: 10.1124/Jpet.120.266023 |
0.781 |
|
| 2019 |
Aksenova M, Sybrandt J, Cui B, Sikirzhytski V, Ji H, Odhiambo D, Lucius MD, Turner JR, Broude E, Peña E, Lizarraga S, Zhu J, Safro I, Wyatt MD, Shtutman M. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 31802418 DOI: 10.1007/S11481-019-09885-8 |
0.411 |
|
| 2019 |
Sun WL, Quizon PM, Yuan Y, Strauss MJ, McCain R, Zhan CG, Zhu J. Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport. Scientific Reports. 9: 3843. PMID 30846720 DOI: 10.1038/S41598-019-39872-1 |
0.834 |
|
| 2018 |
Yuan Y, Zhu J, Zhan CG. Flipped phenyl ring orientations of dopamine binding with human and drosophila dopamine transporters: Remarkable role of three non-conserved residues. Acs Chemical Neuroscience. PMID 29494767 DOI: 10.1021/Acschemneuro.8B00030 |
0.435 |
|
| 2017 |
Zhu J, Ananthan S, Zhan CG. The role of human dopamine transporter in NeuroAIDS. Pharmacology & Therapeutics. PMID 28987321 DOI: 10.1016/J.Pharmthera.2017.10.007 |
0.54 |
|
| 2017 |
Sun WL, Quizon PM, Yuan Y, Zhang W, Ananthan S, Zhan CG, Zhu J. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. Scientific Reports. 7: 3694. PMID 28623359 DOI: 10.1038/S41598-017-03771-0 |
0.808 |
|
| 2017 |
Zhu J, Sun W, Ananthan S, zhan C. Tyrosine470 and 88 of human dopamine transporter are responsible for the allosteric modulatory effect of SRI-30827, SRI-20041 and HIV-1 tat protein on dopamine transporter Drug and Alcohol Dependence. 171: e225. DOI: 10.1016/J.Drugalcdep.2016.08.613 |
0.506 |
|
| 2016 |
Quizon PM, Sun WL, Yuan Y, Midde NM, Zhan CG, Zhu J. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Scientific Reports. 6: 39048. PMID 27966610 DOI: 10.1038/Srep39048 |
0.836 |
|
| 2016 |
Gao J, Midde N, Zhu J, Terry AV, McInnes C, Chapman JM. Synthesis and biological evaluation of ranitidine analogs as multiple-target-directed cognitive enhancers for the treatment of Alzheimer's disease. Bioorganic & Medicinal Chemistry Letters. PMID 27769620 DOI: 10.1016/J.Bmcl.2016.09.072 |
0.713 |
|
| 2016 |
Yuan Y, Huang X, Zhu J, Zhan CG. Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription. Future Medicinal Chemistry. PMID 27739323 DOI: 10.4155/Fmc-2016-0138 |
0.493 |
|
| 2016 |
Yuan Y, Quizon PM, Sun WL, Yao J, Zhu J, Zhan CG. Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake. Scientific Reports. 6: 27314. PMID 27250920 DOI: 10.1038/Srep27314 |
0.836 |
|
| 2016 |
Sun WL, Quizon PM, Zhu J. Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. Progress in Molecular Biology and Translational Science. 137: 1-40. PMID 26809997 DOI: 10.1016/Bs.Pmbts.2015.10.017 |
0.743 |
|
| 2015 |
Zhu J, Yuan Y, Midde NM, Gomez AM, Sun WL, Quizon PM, Zhan CG. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. Journal of Neurovirology. PMID 26501780 DOI: 10.1007/S13365-015-0391-6 |
0.817 |
|
| 2015 |
Gomez AM, Altomare D, Sun WL, Midde NM, Ji H, Shtutman M, Turner JR, Creek KE, Zhu J. Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26232787 DOI: 10.1093/Ijnp/Pyv090 |
0.786 |
|
| 2015 |
Zhu J, Midde NM, Gomez AM, Sun WL, Harrod SB. Intra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats. Frontiers in Microbiology. 6: 540. PMID 26150803 DOI: 10.3389/Fmicb.2015.00540 |
0.816 |
|
| 2015 |
Yuan Y, Huang X, Midde NM, Quizon PM, Sun WL, Zhu J, Zhan CG. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter. Acs Chemical Neuroscience. 6: 658-65. PMID 25695767 DOI: 10.1021/Acschemneuro.5B00001 |
0.808 |
|
| 2015 |
Midde NM, Yuan Y, Quizon PM, Sun WL, Huang X, Zhan CG, Zhu J. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 122-35. PMID 25604666 DOI: 10.1007/S11481-015-9583-3 |
0.835 |
|
| 2015 |
Gomez AM, Sun WL, Midde NM, Harrod SB, Zhu J. Effects of environmental enrichment on ERK1/2 phosphorylation in the rat prefrontal cortex following nicotine-induced sensitization or nicotine self-administration. The European Journal of Neuroscience. 41: 109-19. PMID 25328101 DOI: 10.1111/Ejn.12758 |
0.789 |
|
| 2015 |
Zhu J, Gomez AM, Sun W, Altomare D, Creek KE, Harrod SB. Effects of environmental enrichment on microRNA-221 expression and ERK phosphorylation in the rat prefrontal cortex following nicotine-induced sensitization or nicotine self-administration Drug and Alcohol Dependence. 156: e245. DOI: 10.1016/J.Drugalcdep.2015.07.660 |
0.726 |
|
| 2015 |
Zhu J, Bertrand B, Harrod S, Mactutus C, Booze R. HIV-1 transgenic rats exhibit attenuated cocaine-mediated increase in synaptosomal [3H] dopamine uptake in striatum following cocaine self-administration Drug and Alcohol Dependence. 146: e32. DOI: 10.1016/J.Drugalcdep.2014.09.767 |
0.477 |
|
| 2015 |
Gomez M, Altomare D, Harrod S, Creek K, Zhu J. Environmental enrichment decreases nicotine self-administration and attenuates nicotine- mediated enhancement of orexin-1 receptor gene expression and ERK1/2 activity in rat prefrontal cortex Drug and Alcohol Dependence. 146: e123. DOI: 10.1016/J.Drugalcdep.2014.09.253 |
0.368 |
|
| 2013 |
Midde NM, Huang X, Gomez AM, Booze RM, Zhan CG, Zhu J. Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 975-87. PMID 23645138 DOI: 10.1007/S11481-013-9464-6 |
0.835 |
|
| 2013 |
Garcia-Olivares J, Torres-Salazar D, Owens WA, Baust T, Siderovski DP, Amara SG, Zhu J, Daws LC, Torres GE. Inhibition of dopamine transporter activity by G protein βγ subunits. Plos One. 8: e59788. PMID 23555781 DOI: 10.1371/Journal.Pone.0059788 |
0.415 |
|
| 2013 |
Zhu J, Bardo MT, Dwoskin LP. Distinct effects of enriched environment on dopamine clearance in nucleus accumbens shell and core following systemic nicotine administration. Synapse (New York, N.Y.). 67: 57-67. PMID 23065942 DOI: 10.1002/Syn.21615 |
0.663 |
|
| 2013 |
Gomez AM, Midde NM, Mactutus CF, Booze RM, Zhu J. Correlations of the phosphorylation state of DARPP-32 at Thr34 in PFC with locomotor activity for EC, IC, and SC saline-treated rats. Plos One. DOI: 10.1371/Journal.Pone.0044149.G006 |
0.709 |
|
| 2012 |
Gomez AM, Midde NM, Mactutus CF, Booze RM, Zhu J. Environmental enrichment alters nicotine-mediated locomotor sensitization and phosphorylation of DARPP-32 and CREB in rat prefrontal cortex. Plos One. 7: e44149. PMID 22952905 DOI: 10.1371/Journal.Pone.0044149 |
0.804 |
|
| 2012 |
Midde NM, Gomez AM, Zhu J. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 629-39. PMID 22570010 DOI: 10.1007/S11481-012-9369-9 |
0.839 |
|
| 2012 |
Guo N, Yao W, Wang SR, Zhu J, Huang D, Zuo PL, Kang XJ, Fu CL, Zhou Z, Zhang B. Nicotine dynamically modulates dopamine clearance in rat striatum in vivo. Neurochemistry International. 60: 355-9. PMID 22310173 DOI: 10.1016/J.Neuint.2012.01.022 |
0.332 |
|
| 2011 |
Harrod SB, Lacy RT, Zhu J, Hughes BA, Perna MK, Brown RW. Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse (New York, N.Y.). 65: 1382-92. PMID 21990022 DOI: 10.1002/Syn.20975 |
0.37 |
|
| 2011 |
Zhu J, Ananthan S, Mactutus CF, Booze RM. Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity. Synapse (New York, N.Y.). 65: 1251-4. PMID 21538554 DOI: 10.1002/Syn.20949 |
0.414 |
|
| 2011 |
Midde NM, Gomez AM, Harrod SB, Zhu J. Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacology, Biochemistry, and Behavior. 98: 587-97. PMID 21420997 DOI: 10.1016/J.Pbb.2011.03.013 |
0.813 |
|
| 2011 |
Wooters TE, Bardo MT, Dwoskin LP, Midde NM, Gomez AM, Mactutus CF, Booze RM, Zhu J. Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics. Behavioural Brain Research. 219: 98-107. PMID 21219939 DOI: 10.1016/J.Bbr.2011.01.001 |
0.814 |
|
| 2009 |
Zhu J, Mactutus CF, Wallace DR, Booze RM. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 329: 1071-83. PMID 19325033 DOI: 10.1124/Jpet.108.150144 |
0.528 |
|
| 2009 |
Zhu J, Apparsundaram S, Dwoskin LP. Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 328: 931-9. PMID 19088301 DOI: 10.1124/Jpet.108.147025 |
0.639 |
|
| 2008 |
Zhu J, Reith MEA. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse Cns and Neurological Disorders - Drug Targets. 7: 393-409. PMID 19128199 DOI: 10.2174/187152708786927877 |
0.389 |
|
| 2007 |
Zhu J, Bardo MT, Green TA, Wedlund PJ, Dwoskin LP. Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environment. Journal of Neurochemistry. 103: 2575-88. PMID 17953677 DOI: 10.1111/J.1471-4159.2007.04951.X |
0.662 |
|
| 2007 |
Zhu J, Bardo MT, Bruntz RC, Stairs DJ, Dwoskin LP. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. The European Journal of Neuroscience. 26: 717-28. PMID 17651428 DOI: 10.1111/J.1460-9568.2007.05690.X |
0.647 |
|
| 2005 |
Sumithran SP, Crooks PA, Xu R, Zhu J, Deaciuc AG, Wilkins LH, Dwoskin LP. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity. The Aaps Journal. 7: E201-17. PMID 16146341 DOI: 10.1208/Aapsj070119 |
0.791 |
|
| 2005 |
Zhu J, Apparsundaram S, Bardo MT, Dwoskin LP. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. Journal of Neurochemistry. 93: 1434-43. PMID 15935059 DOI: 10.1111/J.1471-4159.2005.03130.X |
0.659 |
|
| 2005 |
Zheng G, Dwoskin LP, Deaciuc AG, Zhu J, Jones MD, Crooks PA. Lobelane analogues as novel ligands for the vesicular monoamine transporter-2. Bioorganic & Medicinal Chemistry. 13: 3899-909. PMID 15911306 DOI: 10.1016/J.Bmc.2005.04.013 |
0.508 |
|
| 2004 |
Neugebauer NM, Cunningham ST, Zhu J, Bryant RI, Middleton LS, Dwoskin LP. Effects of environmental enrichment on behavior and dopamine transporter function in medial prefrontal cortex in adult rats prenatally treated with cocaine. Brain Research. Developmental Brain Research. 153: 213-23. PMID 15527889 DOI: 10.1016/J.Devbrainres.2004.09.001 |
0.605 |
|
| 2004 |
Dwoskin LP, Sumithran SP, Zhu J, Deaciuc AG, Ayers JT, Crooks PA. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents. Bioorganic & Medicinal Chemistry Letters. 14: 1863-7. PMID 15050617 DOI: 10.1016/J.Bmcl.2003.10.073 |
0.551 |
|
| 2004 |
Zhu J, Green T, Bardo MT, Dwoskin LP. Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex. Behavioural Brain Research. 148: 107-17. PMID 14684252 DOI: 10.1016/S0166-4328(03)00190-6 |
0.675 |
|
| 2003 |
Zhu J, Crooks PA, Ayers JT, Sumithran SP, Dwoskin LP. N-n-Alkylnicotinium and N-n-Alkylpyridinium Analogs Inhibit the Dopamine Transporter: Selectivity as Nicotinic Receptor Antagonists Drug Development Research. 60: 270-284. DOI: 10.1002/Ddr.10328 |
0.626 |
|
| 2002 |
Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA. bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors. Bioorganic & Medicinal Chemistry Letters. 12: 3067-71. PMID 12372503 DOI: 10.1016/S0960-894X(02)00687-X |
0.569 |
|
| 2002 |
Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. Biochemical Pharmacology. 63: 1499-505. PMID 11996892 DOI: 10.1016/S0006-2952(02)00910-3 |
0.634 |
|
| 2000 |
Zhu J, Taniguchi T, Tanaka T, Suzuki F, Muramatsu I. Effects of perinatal nicotine exposure on development of [3H]hemicholinium-3 binding sites in rat neonate brain. Japanese Journal of Pharmacology. 84: 32-35. PMID 11043450 DOI: 10.1254/Jjp.84.32 |
0.38 |
|
| 2000 |
Zhu J, Taniguchi T, Takauji R, Suzuki F, Tanaka T, Muramatsu I. Inverse agonism and neutral antagonism at a constitutively active alpha-1a adrenoceptor. British Journal of Pharmacology. 131: 546-552. PMID 11015306 DOI: 10.1038/Sj.Bjp.0703584 |
0.321 |
|
| 1999 |
Takita M, Taniguchi T, Zhu J, Piao H, Tsai T, Muramatsu I. Effects of chronic treatment with (+)-nicotine on the stress-induced hypertension and downregulation of central nicotinic receptors in rats: comparative study with (-)-nicotine. General Pharmacology-the Vascular System. 33: 29-33. PMID 10428013 DOI: 10.1016/S0306-3623(98)00263-8 |
0.336 |
|
| 1998 |
Zhu J, Taniguchi T, Konishi Y, Mayumi M, Muramatsu I. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates. Life Sciences. 62: 1089-1098. PMID 9519811 DOI: 10.1016/S0024-3205(98)00032-0 |
0.344 |
|
| 1997 |
Zhu J, Takita M, Konishi Y, Sudo M, Muramatsu I. Chronic nicotine treatment delays the developmental increase in brain muscarinic receptors in rat neonate. Brain Research. 732: 257-60. PMID 8891294 DOI: 10.1016/0006-8993(96)00704-4 |
0.376 |
|
| Show low-probability matches. |